LARYNX SQUAMOUS CELL CARCINOMA
Clinical trials for LARYNX SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LARYNX SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LARYNX SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on tough head & neck cancers
Disease control Recruiting nowThis study is testing whether a combination of two drugs, sacituzumab govitecan and cetuximab, can help control advanced head and neck cancer that has come back or spread after initial treatment. It will involve about 40 adults whose cancer has progressed despite standard therapy…
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New weekly combo aims to control aggressive Head/Neck cancer
Disease control Recruiting nowThis study is testing a weekly combination of chemotherapy and immunotherapy for people with advanced head and neck cancer that has spread and who cannot take a standard chemotherapy drug called 5-FU. The goal is to see if this weekly schedule helps shrink tumors and control the …
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Hospital's new alert system aims to slash dangerous cancer treatment delays
Disease control Recruiting nowThis study is testing a new hospital coordination system designed to help patients with head and neck cancer start their follow-up radiation therapy faster after surgery. Long delays between surgery and radiation are common and linked to worse outcomes. The system uses automated …
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC
-
Scientists hunt blood clues to personalize cancer care
Knowledge-focused Recruiting nowThis study aims to find immune system markers in blood, saliva, and stool that can predict how well a different chemotherapy drug works for head and neck cancer patients who cannot take the standard drug. Researchers will analyze samples from 250 patients receiving chemoradiother…
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC